EPDA Logo
Sunday, 06 July 2008
This section provides a summary of the drug information for Zelapar® (selegiline hydrochloride). It is still important that you read the full package leaflet that accompanies the product carefully before you start to take any medication. If you have any further questions about your Pd medication, or other aspects of your Pd treatment, you should discuss these with your doctor or other healthcare professional.

Zelapar® (selegiline)

 

Zelapar® contain the active ingredient selegiline hydrochloride, which is a type of medicine called a selective monoamine-oxidase-B inhibitor (MAOI-B).

Selegiline increases the levels of a substance in the brain called dopamine, and is used in the treatment of Parkinson's disease.

 

 

 

Currently we do not have any further information on Zelapar®.